Cargando…

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study

INTRODUCTION: Bipolar Disorder (BD) has been suggested to be a risk factor for development of Parkinson Disease. Psychiatric drugs used as standard treatment of BD includes many drugs that are known to induce drug-induced parkinsonism (DIP). OBJECTIVES: Clinical differentiation between PD and DIP is...

Descripción completa

Detalles Bibliográficos
Autores principales: D’agostino, G., Cascino, G., Landolfi, A. M., Erro, R., Barone, P., Monteleone, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434513/
http://dx.doi.org/10.1192/j.eurpsy.2023.1090
_version_ 1785091909469863936
author D’agostino, G.
Cascino, G.
Landolfi, A. M.
Erro, R.
Barone, P.
Monteleone, P.
author_facet D’agostino, G.
Cascino, G.
Landolfi, A. M.
Erro, R.
Barone, P.
Monteleone, P.
author_sort D’agostino, G.
collection PubMed
description INTRODUCTION: Bipolar Disorder (BD) has been suggested to be a risk factor for development of Parkinson Disease. Psychiatric drugs used as standard treatment of BD includes many drugs that are known to induce drug-induced parkinsonism (DIP). OBJECTIVES: Clinical differentiation between PD and DIP is a clinical and scientific crucial result. It might be aided by functional neuroimaging of the dopaminergic nigrostriatal pathway. METHODS: Twenty consecutive BD patients with parkinsonism were clinically assessed and underwent (123)I-ioflupane dopamine transporter SPECT. Imaging data of BD patients with pathological nigrostriatal pathway were further compared to a population of de-novo PD patients. RESULTS: Four BD patients had abnormal scans; they had higher putaminal binding ratio and putamen-to-caudate ratios than PD patients, despite similar motor symptom burden. CONCLUSIONS: in our initial results, up to 20% of BD patients with parkinsonism might have an underlying dopaminergic deficit, which is higher than excepted in the general population. This evidences supports that BD represents a risk factor for subsequent development of neurodegenerative parkinsonism. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10434513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104345132023-08-18 Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study D’agostino, G. Cascino, G. Landolfi, A. M. Erro, R. Barone, P. Monteleone, P. Eur Psychiatry Abstract INTRODUCTION: Bipolar Disorder (BD) has been suggested to be a risk factor for development of Parkinson Disease. Psychiatric drugs used as standard treatment of BD includes many drugs that are known to induce drug-induced parkinsonism (DIP). OBJECTIVES: Clinical differentiation between PD and DIP is a clinical and scientific crucial result. It might be aided by functional neuroimaging of the dopaminergic nigrostriatal pathway. METHODS: Twenty consecutive BD patients with parkinsonism were clinically assessed and underwent (123)I-ioflupane dopamine transporter SPECT. Imaging data of BD patients with pathological nigrostriatal pathway were further compared to a population of de-novo PD patients. RESULTS: Four BD patients had abnormal scans; they had higher putaminal binding ratio and putamen-to-caudate ratios than PD patients, despite similar motor symptom burden. CONCLUSIONS: in our initial results, up to 20% of BD patients with parkinsonism might have an underlying dopaminergic deficit, which is higher than excepted in the general population. This evidences supports that BD represents a risk factor for subsequent development of neurodegenerative parkinsonism. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434513/ http://dx.doi.org/10.1192/j.eurpsy.2023.1090 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
D’agostino, G.
Cascino, G.
Landolfi, A. M.
Erro, R.
Barone, P.
Monteleone, P.
Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title_full Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title_fullStr Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title_full_unstemmed Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title_short Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
title_sort bipolar disorder and parkinson disease: a 123i-fp-cit spect study
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434513/
http://dx.doi.org/10.1192/j.eurpsy.2023.1090
work_keys_str_mv AT dagostinog bipolardisorderandparkinsondiseasea123ifpcitspectstudy
AT cascinog bipolardisorderandparkinsondiseasea123ifpcitspectstudy
AT landolfiam bipolardisorderandparkinsondiseasea123ifpcitspectstudy
AT error bipolardisorderandparkinsondiseasea123ifpcitspectstudy
AT baronep bipolardisorderandparkinsondiseasea123ifpcitspectstudy
AT monteleonep bipolardisorderandparkinsondiseasea123ifpcitspectstudy